← Back to Search

Cigarette Type Switching for Smoking/Cigarette Smoking (MINT Trial)

N/A

Recruiting

Led By Nancy C Jao, PhD

Research Sponsored by Rosalind Franklin University of Medicine and Science

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Men and women between 21-60 years old

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks

Awards & highlights

MINT Trial Summary

This trial aims to investigate how the menthol flavoring in cigarettes may affect the body's inflammation levels, which can be a sign of increased risk for heart disease.

Who is the study for?

This trial is for men and women aged 21-60 who smoke at least 5 menthol cigarettes daily for over a year, can use a smartphone with the LifeData app, and speak English fluently. It's not for those pregnant, breastfeeding, trying to quit smoking, heavy drinkers, users of non-menthol tobacco or illicit drugs, or with severe health/psychiatric conditions.Check my eligibility

What is being tested?

The study investigates if switching cigarette types affects markers in the blood that signal inflammation linked to heart disease risk. Participants will change their usual menthol cigarettes as part of the research to see how it influences these biomarkers.See study design

What are the potential side effects?

Since this trial involves switching cigarette types rather than medication or medical procedures, traditional side effects are not applicable. However, changes in smoking habits could potentially alter cravings or withdrawal symptoms.

MINT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 60 years old.

MINT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cytokine Panel 13

Fibrinogen

high sensitivity C-reactive protein

Secondary outcome measures

Blood pressure

Heart rate

Other outcome measures

Affect

CO level

Nicotine Dependence

+2 more

MINT Trial Design

1Treatment groups

Experimental Treatment

Group I: Cigarette Type SwitchingExperimental Treatment1 Intervention

Participants will be switched from smoking menthol cigarettes to non-menthol cigarettes

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rosalind Franklin University of Medicine and ScienceLead Sponsor

13 Previous Clinical Trials

839 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,840 Previous Clinical Trials

47,852,056 Total Patients Enrolled

Nancy C Jao, PhDPrincipal InvestigatorRosalind Franklin University of Medicine and Science

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being recruited for this ongoing medical study?

"The clinical trial mentioned is currently seeking eligible participants. The initial posting of the trial on January 22, 2024, and its most recent update on the same date indicate that it is an ongoing opportunity for enrollment."

Answered by AI

Which specific criteria must individuals meet in order to qualify for participation in this research?

"To be eligible for this research study, potential participants must have inflammation and fall within the age range of 21 to 60. The trial aims to recruit a total of 68 individuals."

Answered by AI

What is the upper limit for the number of individuals enrolled in this research endeavor?

"Indeed, as indicated by the information on clinicaltrials.gov, this study is currently in the process of enrolling patients. It was first posted on January 22nd, 2024 and last updated on the same day. The aim is to recruit a total of 68 participants from one designated site."

Answered by AI

Is the age criterion for participation in this medical study inclusive of individuals aged 70 and above?

"To participate in this research study, patients must fall within the age range of 21 to 60 years. There is one separate trial available for individuals under the age of 18 and a total of 57 trials targeting participants aged over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Menthol, Inflammation, and Nicotine Transition Study

Nancy Jao 2024. "Menthol, Inflammation, and Nicotine Transition Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06232447.

All > Chicago > Milwaukee